Study Stopped
Departure from the department of the principal investigator
Impact of Age and Geriatric Co-morbidities on Lymphocyte Phenotype in Patients 70 Years of Age and Older
PHENOGERIA
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
An individual's immune profile changes with age, and can sometimes be involved in the development of certain diseases such as infections or cancers, in a process called immunosenescence. Some data tend to show that there is a link between this immune profile and geriatric fragility (autonomy, difficulties with walking, memory, undernutrition, co-morbidities, depression). The aim of this study is to describe this profile, or immune phenotype, and to see if there is a link with the different aspects of geriatric assessment in patients without cancer or infection. In addition, these data will serve as a basis for comparison with the same analyses performed on breast cancer patients at the Centre Georges François Leclerc.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2021
CompletedFirst Posted
Study publicly available on registry
February 26, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedSeptember 8, 2022
September 1, 2022
Same day
February 24, 2021
September 5, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
percentage of immune cells in peripheral blood
technique used: flow cytometry
At inclusion
Study Arms (1)
Seniors
70 years of age and over, inpatients or outpatients
Interventions
during the routine blood test, collection of additional blood samples: * 1 x 5 mL heparinized tube for plasma collection and storage * 1 heparinized 5 mL tube for immunophenotyping * 4 x 10 mL EDTA tubes for white blood cell (WBC) collection and cryopreservation
* clinical examination data * test results to measure the degree of geriatric fatigability * Frailty screening questionnaire for neoplasia patients (G8 score)
Eligibility Criteria
A person at least 70 years of age admitted to the Champmaillot Geriatric Center on an inpatient or outpatient basis.
You may qualify if:
- Male or female aged 70 and over admitted to the Champmaillot Geriatric Center on an inpatient or outpatient basis.
You may not qualify if:
- Person not affiliated to national health insurance system
- Person subject to a measure of legal safeguard (curatorship, etc)
- Person with an acute infection
- Person with suspected cancer or active cancer
- Long-term immunosuppressive or corticosteroid therapy
- HIV and/or HBV and/or HCV positive serology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2021
First Posted
February 26, 2021
Study Start
November 1, 2021
Primary Completion
November 1, 2021
Study Completion
November 1, 2021
Last Updated
September 8, 2022
Record last verified: 2022-09